Terbinafine HydrochlorideThird Party Manufacturing in India

Terbinafine is a synthetic allylamine antifungal agent that exerts its fungicidal effect by selectively inhibiting the enzyme squalene epoxidase, which is a key enzyme in the fungal ergosterol biosynthesis pathway. Ergosterol is an essential structural component of the fungal cell membrane, responsible for maintaining membrane integrity, fluidity, and proper function of membrane-bound proteins. By inhibiting squalene epoxidase, terbinafine blocks the conversion of squalene to 2,3-oxidosqualene, the first step in the cyclization pathway that ultimately produces lanosterol and then ergosterol.

The inhibition of squalene epoxidase leads to two damaging consequences for fungal cells. First, the precursor squalene accumulates to toxic intracellular levels, causing increased membrane permeability, disruption of intracellular organelle function, and direct fungicidal damage. Second, the subsequent depletion of ergosterol further compromises the structural integrity and function of the fungal cell membrane, impairing nutrient transport, signaling, and cellular homeostasis. This dual mechanism produces potent fungicidal activity against a broad spectrum of dermatophytes including Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis.

Terbinafine is highly lipophilic and demonstrates excellent penetration into the stratum corneum, hair follicles, sebum, and nail keratin, where it achieves concentrations far exceeding the minimum inhibitory concentrations for most dermatophytes. It undergoes extensive hepatic metabolism with a terminal elimination half-life of approximately 200 to 400 hours due to slow redistribution from skin and adipose tissue, supporting short-course and pulse-dosing treatment regimens.

Therapeutic Uses

Terbinafine hydrochloride tablets USP 250 mg are indicated for the treatment of fungal infections of the skin, hair, and nails caused by dermatophytes and certain yeasts.

• Onychomycosis: Terbinafine is the treatment of choice for fungal nail infections (onychomycosis) caused by dermatophytes. Its high concentration in nail keratin and fungicidal activity allows for a relatively short treatment course of 6 to 12 weeks, with clinical cure rates superior to other oral antifungal agents.
• Tinea Capitis (Scalp Ringworm): Effective for the treatment of fungal infections of the scalp in both children and adults, terbinafine is particularly useful for Trichophyton tonsurans and Microsporum canis infections.
• Tinea Corporis, Tinea Cruris, and Tinea Pedis: Terbinafine is highly effective for dermatophyte infections of the body, groin, and feet (athlete's foot) and produces high clinical and mycological cure rates.
• Cutaneous Candidiasis: While primarily a dermatophyte antifungal, terbinafine also demonstrates activity against Candida species and may be used for certain Candida skin infections.

Why Manufacturers Choose Terbinafine HCl

Terbinafine hydrochloride is one of the most widely manufactured oral antifungal agents in India. The 250 mg tablet is a standardized dosage form produced by numerous Indian pharmaceutical companies for both the domestic market and global exports. Indian manufacturers supply terbinafine tablets to over 50 countries, including the United States, Europe, and Southeast Asia.

WHO-GMP certified facilities manufacture terbinafine tablets as a core antifungal product. The consistent demand for oral terbinafine, driven by the high prevalence of dermatophyte infections and onychomycosis worldwide, makes it a staple product for PCD pharma franchise companies and third party manufacturing arrangements. Its proven efficacy, well-established safety profile, and predictable market demand make it an indispensable product for any antifungal product line.